Ready to Register?

MyLawCLE All-Access Pass

Best choice

Add the All-Access Pass and get this program —
plus 1,000+ live CLE programs every year.


All specialty & ethics credits included
38 practice areas
New sections: AI & the Law, Practice Management
100s of current and trending legal topics
Nationally recognized and highly experienced presenters

$395 / year — this program included
Register with the All-Access Pass

This program + 1,000+ CLE programs, all year

Or register for just this program

Live Video Broadcast

Live webinar of this one program.
$195 Register

On-Demand Video

Recorded access + self-study credit.
$195 Register

Employed-Physician Compensation After Erlanger: FMV Files, Scienter, and Commercial Reasonableness

A hospital’s own FMV file can become the government’s best evidence of scienter. Audit existing FMV documentation for scienter risk, diagnose the compensation structures DOJ targeted in Erlanger, and build a defensible commercial-reasonableness file across every component of physician pay.

2026-11-30 14:30:00

Program Details

2026-11-30 14:30:00

Program Details

2026-11-30 14:30:00

Over 1,000+ webinars

2026-11-30 14:30:00

Course Overview

The FMV opinion you commissioned may be the first exhibit against you

2026-11-30 14:30:00

Until Erlanger, a fair market value opinion was the hospital’s shield. The DOJ’s theory in United States ex rel. Sullivan v. Erlanger Western Carolina Hospital inverts it. Opinions, referral pro formas, consultant warnings, and compensation spreadsheets become affirmative evidence of what the hospital knew. The 2026 Erlanger orders put that theory in play.

Pay above the stated FMV range, and the opinion itself becomes proof of scienter. Leave call pay, medical directorships, or bonuses out of the opinion, and the gap creates exposure. Keep referral leakage tracking or downstream revenue pro formas in the same file, and the hospital’s position changes. Under SuperValu’s subjective-knowledge standard, a later legal memo cannot fix contemporaneous knowledge. After the OIG’s April 2026 FAQ update, the question is whether the subsidy is commercially reasonable, not merely FMV-compliant.

Attendees leave with a working framework for auditing existing FMV files for scienter risk before an inquiry begins. They gain criteria for a defensible commercial-reasonableness file across base salary, productivity incentives, administrative stipends, and quality-based metrics. And they take away a component-by-component approach to redesigning compensation plans. This is practitioner judgment applied to a client’s actual file, not a doctrine walk-through.

Format

CLE Credit

2h CLE Credits

Level

Intermediate

Length

2

Key topics that will be covered

01
Erlanger’s Core Theory
How the DOJ’s theory in United States ex rel. Sullivan v. Erlanger Western Carolina Hospital reframes the FMV file from shield to exhibit, and what that means for compensation arrangements already in place.
02
FMV-to-Scienter Inversion
How paying above a stated FMV range, omitting call pay, medical directorships, or bonuses, and keeping referral leakage tracking or downstream revenue pro formas in the same file each turn the opinion into proof of scienter.
03
SuperValu’s Knowledge Standard
Why SuperValu’s subjective-knowledge standard means a later legal memo can no longer fix contemporaneous knowledge, and how to assess what the hospital knew and when.
04
Documentation Failure Patterns
Which internal compliance warning practices most commonly become the government’s best evidence of subjective knowledge, and which documentation failures are most likely to survive a motion to dismiss.
05
Commercial Reasonableness Redefined
What ‘commercially reasonable’ requires after the April 2026 OIG FAQ update, and why FMV compliance alone no longer carries a Stark Law, Anti-Kickback Statute, or False Claims Act analysis.
06
Component-by-Component Redesign
How to diagnose wRVU incentives, stacked compensation, and undocumented administrative duties, then rebuild base salary, productivity incentives, administrative stipends, and quality-based metrics into a defensible subsidy file.

Program schedule

clock 2:30 pm - 3:30 pm EST

How the Erlanger Theory Turns a Hospital's FMV File Into Scienter Evidence

This session examines how the DOJ’s theory in United States ex rel. Sullivan v. Erlanger Western Carolina Hospital converts a hospital’s own fair market value documentation—opinions, referral pro formas, consultant warnings, and compensation spreadsheets—into affirmative evidence of scienter under the False Claims Act. Attendees will learn the five specific mechanisms through which an FMV file becomes a liability, the doctrinal role of SuperValu’s subjective-knowledge standard, and the documentation failures most likely to survive a motion to dismiss. Attorneys will leave with a working framework for auditing existing FMV files for scienter risk before litigation or government inquiry begins.

Noam B. FischmanNoam B. Fischman
clock 3:40 pm - 4:40 pm EST

Building the Commercially Reasonable Compensation File: Redesigning Employed-Physician Pay After the April 2026 OIG FAQ

This session examines how hospitals and health systems structure and document employed-physician compensation, so the embedded subsidy is defensible as commercially reasonable—not merely fair-market-value compliant—under the Stark Law, Anti-Kickback Statute, and False Claims Act. Attendees will learn what the OIG’s April 23, 2026, FAQ update means when it confirms that fair market value alone does not resolve Anti-Kickback risk, how to design each compensation component—base salary, productivity incentives, administrative stipends, and quality metrics—to withstand scrutiny, and how stacked arrangements combining employment, medical directorships, and call coverage create exposure. Attorneys will leave with a framework for documenting legitimate business purposes hired and at each annual review, so the compensation file reads as commercially reasonable before anyone asks.

Charles B. OppenheimCharles B. Oppenheim
Michael ShimadaMichael Shimada
Noam B. Fischman

Noam B. Fischman

Akerman LLP

Charles B. Oppenheim

Charles B. Oppenheim

Hooper, Lundy & Bookman

Michael Shimada

Michael Shimada

Hooper, Lundy & Bookman

Noam B. Fischman

Noam B. Fischman

Akerman LLP

Noam B. Fischman co-leads Akerman’s Healthcare Litigation team from Washington, D.C., where he helps hospitals, behavioral health centers, ambulance companies, skilled nursing facilities, pharmaceutical and life sciences companies, and healthcare vendors manage risk from fraud and alleged false claims. He has written repeatedly on the False Claims Act’s knowledge standard, including “SafeCo No More: The Changing Landscape of Scienter under the False Claims Act” in June 2023 and “Mind Games: SCOTUS to Rule on what ‘Knowing’ Means under the False Claims Act” in January 2023, and co-authored Akerman’s January 2026 review of False Claims Act enforcement trends for fiscal year 2025. His healthcare practice spans more than 25 years.

Education & Credentials

Mr. Fischman earned his J.D. with honors from The George Washington University Law School in 1999, where he was Notes Editor of The Environmental Lawyer, and his B.A. with high honors from the Rutgers University Honors Program in 1996, where he was an Undergraduate Associate of the Eagleton Institute of Politics. He is admitted to the bars of the District of Columbia, Maryland, and Virginia, and to the U.S. Courts of Appeals for the District of Columbia, Fourth, and Ninth Circuits and the U.S. District Courts for the District of Columbia and the District of Maryland.

Recognition & Leadership

He leads Akerman's Healthcare Litigation team as Co-Team Leader and, before joining the firm in March 2022, chaired the Mergers & Acquisitions Litigation Working Group at Polsinelli. He was named The Capital Pro Bono Honor Roll in 2023 and was recognized as a Rising Star by Super Lawyers Magazine for Washington, D.C. in 2013 and 2014. Since July 2025 he has chaired the board of directors of the Bender JCC of Greater Washington, an organization he has served since 2017, beginning as its pro bono general counsel.

Professional Involvement

Mr. Fischman writes and speaks regularly on healthcare enforcement. He co-hosts The Akerman Angle: Health Law Rx podcast, including a December 2025 episode on government healthcare enforcement policies, is a frequent author on Akerman's Health Law Rx blog, co-authored a February 2023 article in the American Health Law Association's Health Law Weekly, and presented a December 2022 Thomson Reuters West LegalEdcenter webinar. He has been quoted on False Claims Act developments by Law360, Bloomberg Law, Corporate Compliance Insights, and Healthcare Risk Management, including on the Eleventh Circuit's September 2026 qui tam ruling.

Experience

His False Claims Act work includes arguing a successful Ninth Circuit appeal for a major ambulance company in multi-year litigation involving hundreds of thousands of allegedly false claims, winning a motion to dismiss for a hospital facing False Claims Act allegations from a senior official, winning a motion to dismiss in a government contracts False Claims Act case, defending an educational institution against False Claims Act allegations concerning government grants, representing a healthcare trade association in responding to Congressional subpoenas, and defending nursing homes challenging Small Business Administration PPP loan determinations. He has conducted an internal investigation for a hospital system on Foreign Corrupt Practices Act risk arising from an international joint venture and dozens of corruption-related due diligence reviews. His broader practice includes fiduciary duty defense, including securing reimbursement of all defendants' fees and costs for five former directors of a life sciences company, commercial disputes, and post-closing litigation in healthcare transactions.
Charles B. Oppenheim

Charles B. Oppenheim

Hooper, Lundy & Bookman

Charles B. Oppenheim is a Partner at Hooper, Lundy & Bookman in Los Angeles and San Francisco whose practice centers on the Stark Law and federal anti-kickback law, fraud and abuse counseling, hospital-physician integration, and value-based arrangements. He co-authored the American Health Law Association’s monograph on the Stark Law, first written in 1998 and now in its eighth edition for 2026, and his work on the statute was cited by the Fourth Circuit Court of Appeals in United States ex rel. Drakeford v. Tuomey in 2015. He has been ranked by Chambers USA as a top California health care attorney every year since 2010.

Education & Credentials

Mr. Oppenheim earned his J.D. from Fordham University School of Law in 1988, where he was a member of the Fordham Law Review, and his B.A. from Cornell University in 1984. He was admitted to the California bar in 1988.

Recognition & Leadership

He was named a Fellow of the American Health Law Association in 2026 and has been listed in Best Lawyers for Health Care Law from 2013 through 2027, in Chambers USA as a top California health care lawyer from 2010 through 2026, in Super Lawyers for Southern California from 2004 through 2026, and among the Daily Journal's Top Health Care Lawyers in California in 2023. He is AV rated by Martindale-Hubbell, received the Leading Lawyer Award from The Ambulatory M&A Advisor in 2015, and appears in Who's Who in America and Who's Who in American Law. He is a past chair of the Los Angeles County Bar Association's Annual Healthcare Law Compliance Symposium and a past chair of the State Bar of California's Health Law Committee of the Business Law Section.

Professional Involvement

Mr. Oppenheim is a member of the American Bar Association Health Law Section, the American Health Lawyers Association, and the California Society for Healthcare Attorneys, and serves on the planning committee of the Los Angeles County Bar Association's Healthcare Law Section. He donates legal services to Los Angeles charities and previously served as Finance Committee Chair and Board Trustee of The Accelerated School, a charter school in South Central Los Angeles.

Experience

His matters include structuring value-based enterprises and arrangements under the Stark Law exceptions that took effect in 2021, and integrating physicians and hospitals through joint ventures and affiliations. Representative engagements include a joint venture among a nonprofit health system's four hospitals, two medical groups, and seventeen community physical therapy centers; a $545 million multistep integration of a professional medical corporation; the October 2021 affiliation of a physician enablement company with more than 125 locations, 400 providers, and 42 specialties; a joint venture between a major California medical center and a Pennsylvania operator of 27 outpatient physical therapy clinics; and ongoing counsel to a tattoo removal business with more than 40 studios through a $50 million private equity investment and acquisitions. His practice also covers mergers and acquisitions, compliance programs, managed care and accountable care organizations, ambulatory surgery centers, and hospice.
Michael Shimada

Michael Shimada

Hooper, Lundy & Bookman

Michael Shimada is an Associate in the San Francisco office of Hooper, Lundy & Bookman who advises hospitals and health systems, physician groups, medical foundations, ambulatory surgery centers, and public health agencies on business transactions and regulatory compliance, including healthcare fraud and abuse laws, the corporate practice of medicine, and licensing. His transactional work includes the employment, professional services, and restrictive covenant agreements through which providers are engaged and compensated. During law school he served as a legal extern in the Civil Fraud Unit of the U.S. Attorney’s Office for the Central District of California.

Education & Credentials

Mr. Shimada earned his J.D. from the University of California, Los Angeles in 2021 and his B.A. from the University of California, Los Angeles in 2016. He was admitted to the California bar in 2021.

Recognition & Leadership

He has been named Best Lawyers: Ones to Watch in Health Care Law for 2026 and 2027.

Professional Involvement

Mr. Shimada is a member of the American Bar Association Health Law Section.

Experience

His practice covers commercial contracting, including employment, professional services, data privacy, restrictive covenant, and intellectual property agreements; mergers and acquisitions; joint ventures; and corporate reorganizations, together with the healthcare-specific regulatory questions those transactions raise. Before joining the firm, he practiced at a global law firm, assisting employers with domestic and cross-border employment matters, employment policies and practices, and the workforce aspects of mergers, acquisitions, reorganizations, and spin-offs. He also served as a summer law clerk in the General Counsel Division of the Los Angeles City Attorney's Office.
Noam B. Fischman

Noam B. Fischman

Akerman LLP

Noam B. Fischman co-leads Akerman’s Healthcare Litigation team from Washington, D.C., where he helps hospitals, behavioral health centers, ambulance companies, skilled nursing facilities, pharmaceutical and life sciences companies, and healthcare vendors manage risk from fraud and alleged false claims. He has written repeatedly on the False Claims Act’s knowledge standard, including “SafeCo No More: The Changing Landscape of Scienter under the False Claims Act” in June 2023 and “Mind Games: SCOTUS to Rule on what ‘Knowing’ Means under the False Claims Act” in January 2023, and co-authored Akerman’s January 2026 review of False Claims Act enforcement trends for fiscal year 2025. His healthcare practice spans more than 25 years.

Education & Credentials

Mr. Fischman earned his J.D. with honors from The George Washington University Law School in 1999, where he was Notes Editor of The Environmental Lawyer, and his B.A. with high honors from the Rutgers University Honors Program in 1996, where he was an Undergraduate Associate of the Eagleton Institute of Politics. He is admitted to the bars of the District of Columbia, Maryland, and Virginia, and to the U.S. Courts of Appeals for the District of Columbia, Fourth, and Ninth Circuits and the U.S. District Courts for the District of Columbia and the District of Maryland.

Recognition & Leadership

He leads Akerman's Healthcare Litigation team as Co-Team Leader and, before joining the firm in March 2022, chaired the Mergers & Acquisitions Litigation Working Group at Polsinelli. He was named The Capital Pro Bono Honor Roll in 2023 and was recognized as a Rising Star by Super Lawyers Magazine for Washington, D.C. in 2013 and 2014. Since July 2025 he has chaired the board of directors of the Bender JCC of Greater Washington, an organization he has served since 2017, beginning as its pro bono general counsel.

Professional Involvement

Mr. Fischman writes and speaks regularly on healthcare enforcement. He co-hosts The Akerman Angle: Health Law Rx podcast, including a December 2025 episode on government healthcare enforcement policies, is a frequent author on Akerman's Health Law Rx blog, co-authored a February 2023 article in the American Health Law Association's Health Law Weekly, and presented a December 2022 Thomson Reuters West LegalEdcenter webinar. He has been quoted on False Claims Act developments by Law360, Bloomberg Law, Corporate Compliance Insights, and Healthcare Risk Management, including on the Eleventh Circuit's September 2026 qui tam ruling.

Experience

His False Claims Act work includes arguing a successful Ninth Circuit appeal for a major ambulance company in multi-year litigation involving hundreds of thousands of allegedly false claims, winning a motion to dismiss for a hospital facing False Claims Act allegations from a senior official, winning a motion to dismiss in a government contracts False Claims Act case, defending an educational institution against False Claims Act allegations concerning government grants, representing a healthcare trade association in responding to Congressional subpoenas, and defending nursing homes challenging Small Business Administration PPP loan determinations. He has conducted an internal investigation for a hospital system on Foreign Corrupt Practices Act risk arising from an international joint venture and dozens of corruption-related due diligence reviews. His broader practice includes fiduciary duty defense, including securing reimbursement of all defendants' fees and costs for five former directors of a life sciences company, commercial disputes, and post-closing litigation in healthcare transactions.
Charles B. Oppenheim

Charles B. Oppenheim

Hooper, Lundy & Bookman

Charles B. Oppenheim is a Partner at Hooper, Lundy & Bookman in Los Angeles and San Francisco whose practice centers on the Stark Law and federal anti-kickback law, fraud and abuse counseling, hospital-physician integration, and value-based arrangements. He co-authored the American Health Law Association’s monograph on the Stark Law, first written in 1998 and now in its eighth edition for 2026, and his work on the statute was cited by the Fourth Circuit Court of Appeals in United States ex rel. Drakeford v. Tuomey in 2015. He has been ranked by Chambers USA as a top California health care attorney every year since 2010.

Education & Credentials

Mr. Oppenheim earned his J.D. from Fordham University School of Law in 1988, where he was a member of the Fordham Law Review, and his B.A. from Cornell University in 1984. He was admitted to the California bar in 1988.

Recognition & Leadership

He was named a Fellow of the American Health Law Association in 2026 and has been listed in Best Lawyers for Health Care Law from 2013 through 2027, in Chambers USA as a top California health care lawyer from 2010 through 2026, in Super Lawyers for Southern California from 2004 through 2026, and among the Daily Journal's Top Health Care Lawyers in California in 2023. He is AV rated by Martindale-Hubbell, received the Leading Lawyer Award from The Ambulatory M&A Advisor in 2015, and appears in Who's Who in America and Who's Who in American Law. He is a past chair of the Los Angeles County Bar Association's Annual Healthcare Law Compliance Symposium and a past chair of the State Bar of California's Health Law Committee of the Business Law Section.

Professional Involvement

Mr. Oppenheim is a member of the American Bar Association Health Law Section, the American Health Lawyers Association, and the California Society for Healthcare Attorneys, and serves on the planning committee of the Los Angeles County Bar Association's Healthcare Law Section. He donates legal services to Los Angeles charities and previously served as Finance Committee Chair and Board Trustee of The Accelerated School, a charter school in South Central Los Angeles.

Experience

His matters include structuring value-based enterprises and arrangements under the Stark Law exceptions that took effect in 2021, and integrating physicians and hospitals through joint ventures and affiliations. Representative engagements include a joint venture among a nonprofit health system's four hospitals, two medical groups, and seventeen community physical therapy centers; a $545 million multistep integration of a professional medical corporation; the October 2021 affiliation of a physician enablement company with more than 125 locations, 400 providers, and 42 specialties; a joint venture between a major California medical center and a Pennsylvania operator of 27 outpatient physical therapy clinics; and ongoing counsel to a tattoo removal business with more than 40 studios through a $50 million private equity investment and acquisitions. His practice also covers mergers and acquisitions, compliance programs, managed care and accountable care organizations, ambulatory surgery centers, and hospice.
Michael Shimada

Michael Shimada

Hooper, Lundy & Bookman

Michael Shimada is an Associate in the San Francisco office of Hooper, Lundy & Bookman who advises hospitals and health systems, physician groups, medical foundations, ambulatory surgery centers, and public health agencies on business transactions and regulatory compliance, including healthcare fraud and abuse laws, the corporate practice of medicine, and licensing. His transactional work includes the employment, professional services, and restrictive covenant agreements through which providers are engaged and compensated. During law school he served as a legal extern in the Civil Fraud Unit of the U.S. Attorney’s Office for the Central District of California.

Education & Credentials

Mr. Shimada earned his J.D. from the University of California, Los Angeles in 2021 and his B.A. from the University of California, Los Angeles in 2016. He was admitted to the California bar in 2021.

Recognition & Leadership

He has been named Best Lawyers: Ones to Watch in Health Care Law for 2026 and 2027.

Professional Involvement

Mr. Shimada is a member of the American Bar Association Health Law Section.

Experience

His practice covers commercial contracting, including employment, professional services, data privacy, restrictive covenant, and intellectual property agreements; mergers and acquisitions; joint ventures; and corporate reorganizations, together with the healthcare-specific regulatory questions those transactions raise. Before joining the firm, he practiced at a global law firm, assisting employers with domestic and cross-border employment matters, employment policies and practices, and the workforce aspects of mergers, acquisitions, reorganizations, and spin-offs. He also served as a summer law clerk in the General Counsel Division of the Los Angeles City Attorney's Office.

Credits by state

AK2.0
AL2.0
AR2.0
AZ2.0
CA2.0
CO2.0
CT2.0
DC2.0
DE2.0
FL2.0
GA2.0
HI2.0
IA2.0
ID2.0
IL2.0
IN2.0
KS2.0
KY2.0
LA2.0
MA2.0
MD2.0
ME2.0
MI2.0
MN2.0
MO2.4
MS2.0
MT2.0
NC2.0
ND2.0
NE2.0
NH120.0
NJ2.0
NM2.0
NV2.0
NY2.0
OH2.0
OK2.5
OR2.0
PA2.0
RI2.5
SC2.0
SD2.0
TN2.0
TX2.0
UT2.0
VA2.0
VT2.0
WA2.0
WI2.0
WV2.4
WY2.0

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

10,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

MCLE Credits

Alabama
Pending
Alaska
Approved
Arizona
Approved
Arkansas
Approved
California
Approved
Colorado
Pending
Connecticut
Approved
Delaware
Pending
District of Columbia
No Required
Florida
Approved
Georgia
Pending
Hawaii
Approved
Idaho
Pending
Illinois
Pending
Indiana
Pending
Iowa
Pending
Kansas
Pending
Kentucky
Pending
Louisiana
Pending
Maine
Pending
Maryland
No Required
Massachusetts
No Required
Michigan
No Required
Minnesota
Pending
Mississippi
Pending
Missouri
Approved
Montana
Pending
Nebraska
Pending
Nevada
Pending
New Hampshire
Approved
New Jersey
Approved
New Mexico
Approved
New York
Approved
North Carolina
Pending
North Dakota
Approved
Ohio
Pending
Oklahoma
Pending
Oregon
Pending
Pennsylvania
Approved
Rhode Island
Pending
South Carolina
Pending
South Dakota
No Required
Tennessee
Pending
Texas
Approved
Utah
Pending
Vermont
Approved
Virginia
Not Eligible
Washington
Approved
West Virginia
Pending
Wisconsin
Pending
Wyoming
Pending

Alabama

Requirements

The Alabama State Bar MCLE Commission requires attorneys to complete 12 credits, including 1 ethics, by December 31 of each year. All credits must be reported by February 15 of the following year. A maximum of 12 credits, including 1 ethics credit, may be carried over for 1 year only.  

Formats

  • Attorneys can earn unlimited “live” credit through live seminars, live webcasts, and co-sponsored locations with MyLAWCLE-Alabama approved programs
  • Attorneys are limited to 6 credits per compliance period of “online” programs through MyLAwCLE On-Demand programs